ATIM-08. A PHASE I TRIAL OF PEMBROLIZUMAB AND VORINOSTAT COMBINED WITH TEMOZOLOMIDE AND RADIATION THERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA (NCT03426891)

NCOG-18. PHASE I TRIAL OF DIMETHYL FUMARATE, TEMOZOLOMIDE AND RADIATION THERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME: A PRELIMINARY NEUROCOGNITIVE PERSPECTIVE

Neuro-Oncology ◽

10.1093/neuonc/nox168.579 ◽

2017 ◽

Vol 19 (suppl_6) ◽

pp. vi141-vi142

Author(s):

Ashlee Loughan ◽

Danielle Shafer ◽

Autumn Lanoye ◽

Sarah Braun ◽

Paul Dent ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase I ◽

Phase I Trial ◽

Dimethyl Fumarate ◽

Newly Diagnosed ◽

Abstract C56: NCCTG phase I trial of everolimus (RAD001) and temozolomide (TMZ) in combination with radiation therapy (RT) in newly diagnosed glioblastoma multiforme (GBM) patients

10.1158/1535-7163.targ-09-c56 ◽

2009 ◽

Author(s):

Jann N. Sarkaria ◽

Evanthia Galanis ◽

Patrick Peller ◽

Paul Brown ◽

Wenting Wu ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase I ◽

Phase I Trial ◽

Newly Diagnosed ◽

A Phase I Trial of Tipifarnib With Radiation Therapy, With and Without Temozolomide, for Patients With Newly Diagnosed Glioblastoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.07.1997 ◽

2011 ◽

Vol 81 (5) ◽

pp. 1422-1427 ◽

Cited By ~ 17

Author(s):

Phioanh Leia Nghiemphu ◽

Patrick Y. Wen ◽

Kathleen R. Lamborn ◽

Jan Drappatz ◽

H. Ian Robins ◽

...

Keyword(s):

Radiation Therapy ◽

Phase I ◽

Phase I Trial ◽

Newly Diagnosed ◽

North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.05.064 ◽

2011 ◽

Vol 81 (2) ◽

pp. 468-475 ◽

Cited By ~ 52

Author(s):

Jann N. Sarkaria ◽

Evanthia Galanis ◽

Wenting Wu ◽

Patrick J. Peller ◽

Caterina Giannini ◽

...

Keyword(s):

Radiation Therapy ◽

Treatment Group ◽

Glioblastoma Multiforme ◽

Phase I ◽

Cancer Treatment ◽

Phase I Trial ◽

Newly Diagnosed ◽

North Central ◽

Abstract 2654: GAPVAC-101 phase I trial: First data of an innovative actively personalized peptide vaccination trial in patients with newly diagnosed glioblastoma

10.1158/1538-7445.am2016-2654 ◽

2016 ◽

Cited By ~ 1

Author(s):

Norbert Hilf ◽

Katrin Frenzel ◽

Sabrina Kuttruff-Coqui ◽

Sandra Heesch ◽

Sebastian Kreiter ◽

...

Keyword(s):

Phase I ◽

Phase I Trial ◽

Newly Diagnosed ◽

Peptide Vaccination ◽

Vaccination Trial ◽

ATNT-11A PHASE I PHARMACODYNAMIC STUDY OF DISULFIRAM AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA AFTER RADIATION THERAPY AND CONCURRENT TEMOZOLOMIDE

Neuro-Oncology ◽

10.1093/neuonc/nov205.11 ◽

2015 ◽

Vol 17 (suppl 5) ◽

pp. v12.3-v12

Author(s):

Jiayi Huang ◽

Jian Campian ◽

Amit Gujar ◽

David Tran ◽

A. Craig Lockhart ◽

...

Keyword(s):

Radiation Therapy ◽

Phase I ◽

Newly Diagnosed ◽

Pharmacodynamic Study

A Phase I Dose per Fraction Escalation Study of Hypofractionated Intensity-modulated Radiation Therapy with Temozolomide Chemotherapy for Patients with Newly Diagnosed Glioblastoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.07.251 ◽

2009 ◽

Vol 75 (3) ◽

pp. S103

Author(s):

C. Chen ◽

D. Damek ◽

A. Waziri ◽

L.E. Gaspar ◽

K. Lillehei ◽

...

Keyword(s):

Radiation Therapy ◽

Phase I ◽

Intensity Modulated Radiation Therapy ◽

Newly Diagnosed ◽

Intensity Modulated ◽

Temozolomide Chemotherapy ◽

Dose Per Fraction

Phase I trial of combination of antitumor immunotherapy targeted against cytomegalovirus (CMV) plus regulatory T-cell inhibition in patients with newly-diagnosed glioblastoma multiforme (GBM).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e13518 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e13518-e13518

Author(s):

Gordana Vlahovic ◽

Gerald E. Archer ◽

Elizabeth Reap ◽

Annick Desjardins ◽

Katherine B. Peters ◽

...

Keyword(s):

T Cell ◽

Glioblastoma Multiforme ◽

Phase I ◽

Regulatory T Cell ◽

Phase I Trial ◽

Newly Diagnosed ◽

Antitumor Immunotherapy ◽

Cell Inhibition

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma

Cancer Immunology Immunotherapy ◽

10.1007/s00262-012-1319-0 ◽

2012 ◽

Vol 62 (1) ◽

pp. 125-135 ◽

Cited By ~ 204

Author(s):

Surasak Phuphanich ◽

Christopher J. Wheeler ◽

Jeremy D. Rudnick ◽

Mia Mazer ◽

HongQian Wang ◽

...

Keyword(s):

Dendritic Cell ◽

Phase I ◽

Phase I Trial ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Newly Diagnosed ◽

ACTR-14. PHASE I STUDY OF AZD1775 WITH RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) AND EVALUATION OF INTRATUMORAL DRUG DISTRIBUTION (IDD) IN PATIENTS WITH RECURRENT GBM

Neuro-Oncology ◽

10.1093/neuonc/noy148.048 ◽

2018 ◽

Vol 20 (suppl_6) ◽

pp. vi13-vi14 ◽

Cited By ~ 2

Author(s):

Brian Alexander ◽

Jeffrey Supko ◽

Nathalie Agar ◽

Manmeet Ahluwalia ◽

Arati Desai ◽

...

Keyword(s):

Radiation Therapy ◽

Phase I ◽

Phase I Study ◽

Drug Distribution ◽

Newly Diagnosed ◽

Recurrent Gbm